Scientists have made a key breakthrough in treating respiratory diseases by developing a new drug delivery system that ...

The sodium glucose cotransporter 2 (SGLT-2) inhibitor drug dapagliflozin, widely used to treat type 2 diabetes, also shows ...

These diseases require specialty treatment typically unavailable at local retail pharmacies or small health systems, making ...